The healing characteristics, durability, and long-term complications of vascular prostheses

Complications in Vascular Surgery, Second Edition

Volumn , Issue , 2004, Pages 83-138

  Hunter, Glenn C ^a   Bull, David A ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953061191     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (212)

1. Pourdeyhimi B, Wagner D. On the correlation between the failure of vascular grafts and their structural and material properties: A critical analysis. 1 Biomed Mater Res 1986; 20(3): 375-409.
2. Sauvage LR. Biologic behavior of grafts in arterial system. In: Haimovici H, ed. Vascular Surgery 3rd ed. East Norwalk: Appleton and Lange, 1989: 136-160.
3. Malone JM, Moore WS, Goldstone J. The natural history of bilateral aortofemoral bypass grafts for ischemia of the lower extremities. Arch Surg 1975; 110(11): 1300-1306.
4. Szilagyi DE, Elliott IP Jr, Smith RF, Reddy DJ. McPhariin M. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J Vasc Surg 1986; 3(3): 421-436.
5. Nevelsteen A, Wouters L, Suy R. Aortofemoral dacron reconstruction for aorto-iliac occlusive disease: a 25-year survey. Eur J Vasc Surg 1991; 5(2): 179-186.
6. Green RM, Abbott WM, Matsumoto T, Wheeler JR, Miller N, Veith FJ. et al. Prosthetic above-knee femoropopliteal bypass grafting: Five-year results of a randomized trial. J Vasc Surg 2000; 31(3): 417-425.
7. el-Massry S, Saad E, Sauvage LR, Zammit M, Smith Ie, Davis CC, et al. Femoropopliteal bypass with externally supported knitted Dacron grafts: A follow-up of 200 grafts for one to twelve years. J Vasc Surg 1994; 19(3): 487-494.
8. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein. and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: A prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000; 32(2): 268-277.
9. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, Freischlag JA, Ahn SS, Baker JD, et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 1992; 16(2): 209-217.
10. Guidoin R. A biological and structural evaluation of retrieved Dacron arterial prostheses US Department of Commerce/National Bureau of Standards Implant Retrieval: Material and Biological Analysis. 1981.
11. Harris PL. Aorto-iliac-femoral re-operative surgery. Supplementary surgery at secondary operations. Acta Chir Scand Suppl 1987; 538: 51-55.
12. el-Massry S, Saad E, Sauvage LR, Zammit M, Davis CC, Smith JC, et al. Axillofemoral bypass with externally supported, knitted Dacron grafts: A follow-up through twelve years. J Vasc Surg 1993; 17(1): 107-115.
13. Mii S, Mori A, Sakata H, Kawazoe N. Fifteen-year experience in axillofemoral bypass with externally supported knitted Dacron prosthesis in a Japanese hospital. J Am Coli Surg 1998; 186(5): 581-588.
14. Rutherford RB, Patt A, Pearce WH. Extra-anatomic bypass: A closer view. J Vasc Surg 1987; 6(5): 437-446.
15. Madiba TE, Mars M, Robbs JV. Aortobifemoral bypass in the presence of superficial femoral artery occlusion: Does the profunda femoris artery provide adequate runolf? J R Coli Surg Edinb 1998; 43(5): 310-313.
16. Jonas RA, Schoen FJ, Levy RJ, Castaneda AR. Biological sealants and knitted Dacron: porosity and histological comparisons of vascular graft materials with and without collagen and fibrin glue pretreatments. Ann Thorac Surg 1986; 41(6): 657-663.
17. Quinones-Baldrich WJ, Moore WS, Ziomek S, Chvapil M. Development of a “leakproof,” knitted Dacron vascular prosthesis. J Vasc Surg 1986; 3(6): 895-903.
18. Jonas RA, Ziemer G, Schoen FJ, Britton L, Castaneda AR. A new sealant for knitted Dacron prostheses: Minimally cross-linked gelatin. J Vasc Surg 1988; 7(3): 414-419.
19. Kadoba K, Schoen FJ, Jonas RA. Experimental comparison of albumin-sealed and gelatinsealed knitted Dacron conduits. Porosity control, handling, sealant resorption, and healing. J Thorac Cardiovasc Surg 1992; 103(6): 1059-1067.
20. McGee GS, Shuman TA, Atkinson JB, Weaver FA, Edwards WH. Experimental evaluation of a new albumin-impregnated knitted dacron prosthesis. Am Surg 1987; 53(12): 695-701.
21. Bethea MC, Reemtsma K. Graft hemostasis: An alternative to preclotting. Ann Thorac Surg 1979; 27(4): 374.
22. Cooley DA, Ramagnoli A, Nilam JD, Bossort MI. A method of predisposing woven Dacron grafts to prevent interstitial hemorrhage. Cardiovasc Dis (Bull Texas Heart Inst) 1981; 8: 48.
23. Adachi H, Mizuhara A, Yamaguchi A, Murata S, Kamio H, Ino T, et al. Clinical experience of a new gelatin impregnated woven Dacron graft. Japan J Artif Organs 1996; 25(1): 214-219.
24. Wesolow A. The healing of arterial prostheses-the state of the art. Thorac Cardiovasc Surg 1982; 30(4): 196-208.
25. Guidoin R, Gosselin C, Martin L, Marois M, Laroche F, King M, et al. Polyester prostheses as substitutes in the thoracic aorta of dogs. I Evaluation of commercial prostheses. J Biomed Mater Res 1983; 17(6): 1049-1077.
26. Anerson JM. Microvel with hemashield vascular grafts. A preliminary report of the healing response in humans. Angiol Arch Bd 1985; 9: 73-77.
27. Drury JK, Ashton TR, Cunningham JD, Maini R, Pollock JG. Experimental and clinical experience with a gelatin impregnated Dacron prosthesis. Ann Vasc Surg 1987; 1(5): 542-547.
28. Ukpabi P, Marois Y, King M, Deng X, Martin L, Laroche G, et al. The Gelweave polyester arterial prosthesis. Can J Surg 1995; 38(4): 322-331.
29. Farooq M, Freischlag J, Kelly H, Seabrook G, Cambria R, Towne J. Gelatin-sealed polyester resists Staphylococcus epidermidis biofilm infection. J Surg Res 1999; 87(1): 57-61.
30. Prager M, Polterauer P, Bohmig HJ, Wagner O, Fugl A, Kretschmer G, et al. Collagen versus gelatin-coated Dacron versus stretch polytetrafluoroethylene in abdominal aortic bifurcation graft surgery: Results ofa seven-year prospective, randomized multicenter trial. Surgery 2001; 130(3): 408-414.
31. The Canadian Multicenter HemashieJd Study Group. Immunologic response to collagenimpregnated vascular grafts: A randomized prospective study. The Canadian Multicenter Hemashield Study Group. J Vasc Surg 1990; 12(6): 741-746.
32. Knox WG, Miller RE. Long-term appraisal of aortic and arterial homografts implanted in years 1954-1957. Ann Surg 1970; 172(6): 1076-1078.
33. Humphries AW, Hawk WA, DeWolfe VG, Le Fevre FA. Clinicopathologic observations on the fate of arterial freeze-dried homografts. Surgery 1959; 45: 59-71.
34. Cooke PA, Nobis PA, Stoney RJ. Dacron aortic graft failure. Arch Surg 1974; 108(1): 101-103.
35. Perry MO. Early failure of Dacron prosthetic grafts. J Cardiovasc Surg (Torino) 1975; 16(3): 318-321.
36. Blumenberg RM, Gelfand ML. Failure of knitted Dacron as an arterial prosthesis. Surgery 1977; 81(5): 493-496.
37. Nucho RC, Gryboski WA. Aneurysms of a double velour aQrtic graft. Arch Surg 1984; 119(10): 1182-1184.
38. Creech OJ, Deterling RA, Edwards S, Julian OC, Linton RR, Schumacker H. Vascular prostheses: Report of the Committee for the Study of Vascular Prostheses of the Society for Vascular Surgery. Surgery 1957; 41: 62-80.
39. Eastcott HHG. Rupture of Orion aortic graft after six years. Lancet 1962; 2: 75-76.
40. Hayward RH, White RR. Aneurysm in a woven Teflon graft. Angiology 1971; 22(4): 188-190.
41. Campbell CD, Brooks DH, Webster MW, Bondi RP, Lloyd JC, Hynes MF, et al. Aneurysm formation in expanded po1ytetrafluoroethylene prostheses. Surgery 1976; 79(5): 491-493.
42. Roberts AK, Johnson N. Aneurysm formation in an expanded microporous polytetrafluorethylene graft. Arch Surg 1978; 113(2): 211-213.
43. Trippestad A. Dilatation and rupture of Dacron arterial grafts. Acta Chir Scand Suppl 1985; 529: 77-79.
44. Berger K, Sauvage LR. Late fiber deterioration in Dacron arterial grafts. Ann Surg 1981; 193(4): 477-491.
45. Nunn DB, Freeman MH, Hudgins Pc. Postoperative alterations in size of Dacron aortic grafts: An ultrasonic evaluation. Ann Surg 1979; 189(6): 741-745.
46. Lundqvist B, Almgren B, Bowald S, Lorelius LE, Eriksson I. Deterioration and dilatation of Dacron prosthetic grafts. Acta Chir Scand Suppl 1985; 529: 81-85.
47. Berman SS, Hunter GC, Smyth SH, Erdoes LS, McIntyre KE, Bernhard VM. Application of computed tomography for surveillance of aortic grafts. Surgery 1995; 118(1): 8-15.
48. Yashar JJ, Richman MH, Dyckman J, Witoszka M, Burnard RJ, Weyman AK, et al. Failure of Dacron prostheses caused by structural defect. Surgery 1978; 84(5): 659-663.
49. Ratto GB, Truini M, Sacco A, Canepa G, Badini A, Motta G. Multiple aneurysmal dilatations in a knitted Dacron velour graft. J Cardiovasc Surg (Torino) 1985; 26(6): 589-591.
50. King MW, Guidoin R, Blais P, Gayton A, Cunasekera KR. Degradation of polyester arterial prostheses: A physical or chemical mechanism? In: Fraker AC, Griffen CD, eds. Corrosion and Degradation of Implant Materials. Second Symposium, ASTM STP 859. Philadelphia: American Society for Testing and Materials, 1985: 294-307.
51. Rais O, Lundstrom B, Angquist KA, Hallmans G. Bilateral aneurysm of dacron graft following aorto-femoral graft operation. A case report. Acta Chir Scand 1976; 142(6): 479-482.
52. Clagett GP, Salander JM, Eddleman WL, Cabellon S Jr, Youkey JR, Olson DW, et al. Dilation of knitted Dacron aortic prostheses and anastomotic false aneurysms: Etiologic considerations. Surgery 1983; 93(1 Pt 1): 9-16.
53. Gooding GA, Effeney DJ, Goldstone J. The aortofemoral graft: Detection and identification of healing complications by ultrasonography. Surgery 1981; 89(1): 94-101.
54. Clifford PC, Skidmore R, Woodcock JP, Bird DR, Lusby RJ, Baird RN. Arterial grafts imaged using Doppler and real-time ultrasound. Vasc Diagn Ther 1981; 2: 43-58.
55. Qvarfordt PG, Reilly LM, Mark AS, Goldstone J, Wall SD, Ehrenfeld WK, et al. Computerized tomographic assessment of graft incorporation after aortic reconstruction. Am J Surg 1985; 150(2): 227-231.
56. Brown OW, Stanson AW, Pairolero PC, Hollier LH. Computerized tomography following abdominal aortic surgery. Surgery 1982; 91(6): 716-722.
57. Bergan JJ, Yao JS, Flinn WR, McCarthy WJ. Surgical treatment of venous obstruction and insufficiency. J Vasc Surg 1986; 3(1): 174-181.
58. Nunn DB, Carter MM, Donohue MT, Pourdeyhimi B. Dilative characteristics of Microvel and Vasculour-II aortic bifurcation grafts. J Biomed Mater Res 1996; 30(1): 41-46.
59. Kalman PG, Rappaport DC, Merchant N, Clarke K, Johnston KW. The value of late computed tomographic scanning in identification of vascular abnormalities after abdominal aortic aneurysm repair. J Vasc Surg 1999; 29(3): 442-450.
60. Biancari F, Ylonen K, Anttila V, Juvonen J, Romsi P, Satta J, et al. Durability of open repair of infrarenal abdominal aortic aneurysm: A 15-year follow-up study. J Vasc Surg 2002; 35(1): 87-93.
61. Edwards JM, Teefey SA, Zierler RE, Kohler TR. Intraabdominal paraanastomotic aneurysms after aortic bypass grafting. J Vasc Surg 1992; 15(2): 344-353.
62. Mii S, Mori A, Sakata H, Kawazoe N. Para-anastomotic aneurysms: Incidence, risk factors, treatment and prognosis. J Cardiovasc Surg (Torino) 1998; 39(3): 259-266.
63. Locati P, Socrate AM, Costantini E. Paraanastomotic aneurysms of the abdominal aorta: A 15-year experience review. Cardiovasc Surg 2000; 8(4): 274-279.
64. Curl GR, Faggioli GL, Stella A, D’Addato M, Ricotta JJ. Aneurysmal change at or above the proximal anastomosis after infrarenal aortic grafting. J Vasc Surg 1992; 16(6): 855-860.
65. Allen RC, Schneider J, Longenecker L, Smith RB III, Lumsden AB. Paraanastomotic aneurysms of the abdominal aorta. J Vasc Surg 1993; 18(3): 424-432.
66. Szilagyi DE, Smith RF, Elliott JP, Hageman JH, Dall’Olmo CA. Anastomotic aneurysms after vascular reconstruction: Problems of incidence, etiology, and treatment. Surgery 1975; 78(6): 800-816.
67. Kinley CE, Paasche PE, MacDonald AS, Marble AE. Stress at vascular anastomosis in relation to host artery: Synthetic graft diameter. Surgery 1974; 75(1): 28-30.
68. Kim GE, Imparato AM, Nathan I, Riles TS. Dilation of synthetic grafts and junctional aneurysms. Arch Surg 1979; 114(11): 1296-1303.
69. Courbier R, Aboukhater R. Progress in the treatment of anastomotic aneurysms. World J Surg 1988; 12(6): 742-749.
70. Carson SN, Hunter GC, Palmaz J, Guernsey JM. Recurrence of femoral anastomotic aneurysms. Am J Surg 1983; 146(6): 774-778.
71. Nunn DB. Structural failure of first-generation, polyester, double-velour, knitted prostheses. J Vasc Surg 2001; 33(5): 1131-1132.
72. Chakfe N, Riepe G, Dieval F, Le J, Magnen F, Wang L, Urban E, et al. Longitudinal ruptures of polyester knitted vascular prostheses. J Vasc Surg 2001; 33(5): 1015-1021.
73. Biedermann H, Flora G. Fatigue problems in dacron vascular grafts. Int J Artif Organs 1982; 5(3): 205-206.
74. Watanabe T, Kusaba A, Kuma H, Kina M, Okadome K, Inokuchi K. Failure ofDacron arterial prostheses caused by structural defects. J Cardiovasc Surg (Torino) 1983; 24(2): 95-100.
75. Goldstone J. Management of late failures of aorto-femoral reconstructions. Acta Chir Scand Suppl 1990; 555: 149-153.
76. Johnston KW. Nonvascular complications of vascular surgery. Presented at the Seventeenth Annual Symposium on Current Critical Problems and New Horizons in Vascular Surgery, New York, 1990.
77. Wright DJ, Ernst CB, Evans JR, Smith RF, Reddy DJ, Shepard AD, et al. Ureteral complications and aortoiliac reconstruction. J Vasc Surg 1990; 11(1): 29-37.
78. Burns WA, Kanhouwa S, Tillman L, Saini N, Herrmann JB. Fibrosarcoma occurring at the site of a plastic vascular graft. Cancer 1972; 29(1): 66-72.
79. O’Connell TX, Fee HJ, Golding A. Sarcoma associated with Dacron prosthetic material: Case report and review of the literature. J Thorac Cardiovasc Surg 1976; 72(1): 94-96.
80. Fehrenbacher JW, Bowers W, Strate R, Pittman J. Angiosarcoma of the aorta associated with a Dacron graft. Ann Thorac Surg 1981; 32(3): 297-301.
81. Brand KC. Foreign body tumorogenesis, timing and location of preneoplastic events. J Natl Cancer Inst 1971; 47: 829.
82. Cintora I, Pearce DE, Cannon JA. A clinical survey of aortobifemoral bypass using two inherently different graft types. Ann Surg 1988; 208(5): 625-630.
83. Bacchini G, Del Vecchio L, Andrulli S, Pontoriero G, Locatelli F. Survival of prosthetic grafts of different materials after impairment of a native arteriovenous fistula in hemodialysis patients. Asaio J 2001; 47(1): 30-33.
84. Derenoncourt FJ. PTFE for A-V access: six years of experience with 310 reinforced and stretch grafts. In: Henry ML, Ferguson RM, eds. Vascular Access for Hemodialysis-IV. Chicago: Precept Press, 1995: 286-291.
85. Landry GJ, Moneta GL, Taylor LM Jr, Porter JM. Axillobifemoral bypass. Ann Vasc Surg 2000; 14(3): 296-305.
86. Boyce B. Physical characteristics of expanded polytetrafluoroethylene grafts. In: Stanley JC, ed. Biologic and Synthetic Vascular Prostheses. New York: Grune and Stratton, 1982: 553-561.
87. Graham LM, Bergan JJ. Expanded polytetrafluoroethylene vascular grafts: Clinical and experimental observation. In: Stanley JC, ed. Biologic and Synthetic Vascular Prostheses. New York: Grune and Stratton, 1982: 536-586.
88. Clowes AW, Gown AM, Hanson SR, Reidy MA. Mechanisms of arterial graft failure. I. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol 1985; 118(1): 4354.
89. Clowes AW, Kirkman TR, Clowes MM. Mechanisms of arterial graft failure. II Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses. J Vasc Surg 1986; 3(6): 877-884.
90. Quinones-Baldrich WJ, Ziomek S, Henderson T, Moore WS. Primary anastomotic bonding in polytetrafluoroethylene grafts? J Vasc Surg 1987; 5(2): 311-318.
91. Mohring K, Osbach HW, Bersch W, Ikinger U, SchUler PJ. Clinical implications of pathomorphological findings in vascular prostheses. In: Robinson BHB, Hawkins JB, eds. Dialysis, Transplantation Nephrology. London: Pitman, 1978: 582-583.
92. Guidoin R, Chakfe N, Maurel S, How T, Batt M, Marois M, et al. Expanded polytetrafluoroethylene arterial prostheses in humans: Histopathological study of 298 surgically excised grafts. Biomaterials 1993; 14(9): 678-693.
93. Guidoin R, Maurel S. Chakfe N, How T, Zhang Z, Therrien M, et al. Expanded polytetrafluoroethylene arterial prostheses in humans: Chemical analysis of 79 explanted specimens. Biomaterials 1993; 14(9): 704694.
94. Anderson JM, Bennert KW, Johnson JM. The pathology and healing responses of expanded polytetrafluoroethylene vascular access grafts. In: Wilson SE, ed. Vascular Access Surgery. 2nd ed. Chicago: Year Book, 1988: 213-231.
95. Groegler FM, Kapfer X, Meichelbock W. Crural prosthetic revascularization: Randomized, prospective, multicentric comparison of standard and carbon impregnated ePTFE grafts. 27th Global Vascular Endovascular Issues Techniques Horizons Symposium, New York, 2000: 12.112.3.
96. Bacourt F. Prospective randomized study of carbon-impregnated polytetrafluoroethylene grafts for below-knee popliteal and distal bypass: Results at 2 years. The Association Universitaire de Recherche en Chirurgie. Ann Vase Surg 1997; 11(6): 596-603.
97. Mohamed MS, Mukheljee M, Kakkar VV. Thrombogenicity of heparin and non-heparinbound arterial prostheses: An in vitro evaluation. J R Coli Surg Edinb 1998; 43(3): 155157.
98. Iwai Y. Development of a thermal cross-linking heparinization method and its application to small caliber vascular prostheses. Asaio J 1996; 42(5): M693-M697.
99. Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicenter trial. J Vasc Surg 2001; 33(3): 533-539.
100. Herring M, Baughman S, Glover J. Endothelium develops on seeded human arterial prosthesis: A brief clinical note. J Vasc Surg 1985; 2(5): 727-730.
101. Swedenborg J, Bengtsson L, Clyne N, Dryjski M, Gillis C, Rosfors S, et al. In vitro endothelialisation of arteriovenous loop grafts for haemodialysis. Eur J Vasc Endovasc Surg 1997; 13(3): 272-277.
102. Magometschnigg H, Kadletz M, Vodrazka M, Dock W, Grimm M, Grabenwoger M, et al. Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction. J Vasc Surg 1992; 15(3): 527-535.
103. Deutsch M, Meinhart J, Vesely M, Fischlein T, Groscurth P, von Oppell U, et al. In vitro endothelialization of expanded polytetrafluoroethylene grafts: A clinical case report after 41 months of implantation. J Vasc Surg 1997; 25(4): 757-763.
104. Yu H, Wang Y, Eton D, Rowe VL, Terramani TT, Cramer DV, et al. Dual cell seeding and the use of zymogen tissue plasminogen activator to improve cell retention on polytetrafluoroethylene grafts. J Vasc Surg 2001; 34(2): 337-343.
105. Zilla P, Deutsch M, Meinhart J, Fischlein T, Hofmann G. Long-term effects of clinical in vitro endothelialization on grafts. J Vasc Surg 1997; 25(6): 1110-1112.
106. Sipehia R, Martucci G, Lipscombe J. Transplantation of human endothelial cell monolayer on artificial vascular prosthesis: The effect of growth-support surface chemistry, cell seeding density, ECM protein coating, and growth factors. Artif Cells Blood Substit Immobil Biotechnol 1996; 24(1): 51-63.
107. Bellon JM, Garcia-Honduvilla N, Escudero C, Gimeno MJ, Contreras L, de Haro J, et al. Mesothelial versus endothelial cell seeding: Evaluation of cell adherence to a fibroblastic matrix using Ill-In oxine. Eur J Vasc Endovasc Surg 1997; 13(2): 142-148.
108. Shi Q, Wu MH, Hayashida N, Wechezak AR, Clowes AW, Sauvage LR. Proof of fallout endothelialization of impervious Dacron grafts in the aorta and inferior vena cava of the dog. J Vasc Surg 1994; 20(4): 546-557.
109. Scott SM, Barth MG, Gaddy LR, Ahl ET Jr, The role of circulating cells in the healing of vascular prostheses. J Vasc Surg 1994; 19(4): 585-593.
110. Birchall IE, Field PL, Ketharanathan V. Adherence of human saphenous vein endothelial cell monolayers to tissue-engineered biomatrix vascular conduits. J Biomed Mater Res 2001; 56(3): 437-443.
111. Wu MH, Shi Q, Wechezak AR, Clowes AW, Gordon IL, Sauvage LR. Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J Vasc Surg 1995; 21(5): 862-867.
112. Berman SS, Jarrell BE, Raymond MA, Kleinert L, Williams SK. Early experience with ePTFE dialysis grafts sodded with liposuction-derived microvascular endothelial cells. Henry ML, Ferguson RM, eds. Vascular Access for Hemodialysis 1995; Vol IV:. Chicago: Precept Press, 1995: 292-302.
113. Kraiss LW, Kirkman TR, Kohler TR, Zierler B, Clowes AW. Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler Thromb 1991; 11(6): 1844-1852.
114. Mattsson EJ, Kohler TR, Vergel SM, Clowes AW. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Bioi 1997; 17(10): 2245-2249.
115. Batson RC, Sottiurai VS, Craighead CC. Linton patch angioplasty. An adjunct to distal bypass with polytetrafluoroethylene grafts. Ann Surg 1984; 199(6): 684-693.
116. Taylor RS, Loh A, McFarland RJ, Cox M, Chester JF. Improved technique for polytetrafluoroethylene bypass grafting: Long-term results using anastomotic vein patches. Br J Surg 1992; 79(4): 348-354.
117. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 1997; 26(4): 543-550.
118. How TV, Rowe CS, Gilling-Smith GL, Harris PL. Interposition vein cuff anastomosis alters wall shear stress distribution in the recipient artery. J Vasc Surg 2000; 31(5): 1008-1017.
119. Kissin M, Kansal N, Pappas PJ, DeFouw DO, Duran WN, HobsonII RW II. Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts. J Vasc Surg 2000; 31(1 Pt 1): 69-83.
120. Neville RF, Tempesta B, Sidway AN. Tibial bypass for limb salvage using polytetrafluoroethylene and a distal vein patch. J Vasc Surg 2001; 33(2): 266-272.
121. Kreienberg PB, Darling RC III, Chang BB, Paty PS, Lloyd WE, Shah DM. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: Polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs. J Vasc Surg 2000; 31(4): 696-701.
122. Harris PL, How TV. Haemodynamics of cuffed arterial anastomosis. Crit Ischaemia 9(1) 1999;: 20-26.
123. Panneton JM. Early results of the Distafto randomized trial for critical limb ischemia 27th Global Vascular Endovascular Issues Techniques Horizons Symposium, New York. 2000: 14.1-14.2.
124. Lord RSA, Nash PA, Raj BT, Stary DL, Graham AR, Hill DA, et al. Prospective randomized trial of polytetraftuoroethylene and Dacron aortic prosthesis. I Peri operative results. Ann Vasc Surg 2(3) 1988;: 248-254.
125. Friedman SG, Lazzaro RS, Spier LN, Moccio C, Tortolani AJ. A prospective randomized comparison of Dacron and polytetraftuoroethylene aortic bifurcation grafts. Surgery 1995; 117(1): 7-10.
126. Chiesa R, Melissano G, Castellano R, Frigerio S. Extensible expanded polytetrafluoroethylene vascular grafts for aortoiliac and aortofemoral reconstruction. Cardiovasc Surg 2000; 8(7): 538-544.
127. Schuman ES, Standage BA, Ragsdale JW, Gross GF. Reinforced versus nonreinforced polytetraftuoroethylene grafts for hemodialysis access. Am J Surg 1997; 173(5): 407-410.
128. Soroma AJ, Hughes CB, McCarthy JT, Jenson BM, Prieto M, Panneton JM, Sterioff S, Stegall MD, Nyberg SL. Prospective, randornizedevaluation of a cuffed expanded polytetraftuoroethylene graft for hemodialysis vascular access. Surgery 2002; 132: 135-140.
129. Hakaim AG, Scott TE. Durability of early prosthetic dialysis graft cannulation: Results of a prospective, nonrandomized clinical trial. J Vasc Surg 1997; 25(6): 1002-1006.
130. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM. Tilney NL. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985; 202(2): 235-239.
131. Johnson JM, Anderson JM. Reasonable expectations for PTFE grafts in hemodialysis access. Dialysis Transplant 1983; 12(4): 238-240.
132. Escobar FS, Schwartz SA, Abouljoud M, Douzdjian V, Escobar MD, Besarab A, Elliott JP. Comparison of a new “hooded” graft with a conventional ePTFE graft: A preliminary study. In: Henry ML, ed. Vascular Access for Hemodialysis-VI. Chicago: WL Gore & Assoc and Precept Press, 1999: 205-212.
133. Pipinos II, Escobar FSI, Anagnostopoulos PV, Elliott JP, Schwartz S. Early experience with Taylor and notched vein patching in the construction of arteriovenous hemodialysis access procedures: Results of a prospective study. Henry ML ed. Vascular Access for Hemodialysis 1998; Vol VI:. Chicago: Precept Press, 1998: 213-222.
134. Enzler MA, Rajmon T, Lachat M, Largiader F. Long-term function of vascular access for hemodialysis. Clin Transplant 1996; 10(6 Pt 1): 511-515.
135. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34(4): 694-700.
136. Graor RA, Risius B, Denny KM, Young JR, Beven EG, Hertzer NR, et al. Local thrombolysis in the treatment of thrombosed arteries, bypass grafts, and arteriovenous fistulas. J Vasc Surg 1985; 2(3): 406-414.
137. Benenati J, Shlansky-Goldberg R, Meglin A, Seidl E. Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abcixima. The SCVIR Consultants’ Conference; May 22, 2000; Orlando, FL Society for Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 2001; 12(7): 795-805.
138. Rubin JR, Yao JS, Thompson RG, Bergan JJ. Management of infection of major amputation stumps after failed femorodistal grafts. Surgery 1985; 98(4): 810-815.
139. Kaupp HA, Matulewicz TJ, Lattimer GL, Kremen JE, Celani VJ. Graft infection or graft reaction? Arch Surg 1979; 114(12): 1419-1422.
140. Paes E, Vollmar JF, Mohr W, Hamann H, Brecht-Krauss D. Perigraft reaction: Incompatibility of synthetic vascular grafts? New aspects on clinical manifestation, pathogenesis, and therapy. World J Surg 1988; 12(6): 750-755.
141. Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts. Surgery 1985; 97(2): 194-204.
142. Buche M, Schoevaerdts JC, Jaumin P, Ponlot R, Chalant CH. Perigraft• seroma following axillofemoral bypass: Report of three cases. Ann Vasc Surg 1986; 1(3): 374-377.
143. Bhuta I, Dorrough R. Noninfectious fluid collection around velour Dacron graft: Possible allergic reaction. South Med J 1981; 74(7): 870-872.
144. Ahn SS, Machleder HI, Gupta R, Moore WS. Perigraft seroma: Clinical, histologic, and serologic correlates. Am J Surg 1987; 154(2): 173-178.
145. Bolton W, Cannon JA. Seroma formation associated with PTFE vascular grafts used as arteriovenous fistulae. Dial Transplant 1981; 10(1): 60 (62-63,66).
146. Berger RMF, Bol-Raap G, Hop WJ, Bogers AJ, Hess J. Heparin as a risk factor for perigraft seroma complicating the modified Blalock-Taussig shunt. J Thorac Cardiovasc Surg 1998; 116(2): 286-293.
147. LeBlanc JG, Vince DJ, Taylor GP. Perigraft seroma: Long-term complications. J Thorac Cardiovasc Surg 1986; 92(3 Pt 1): 451-454.
148. Ahn SS, Williams DE, Thye DA, Cheng KQ, Lee DA. The isolation of a fibroblast growth inhibitor associated with perigraft seroma. J Vasc Surg 1994; 20(2): 202-208.
149. Siaden JG, Mandl MA, Grossman L, Denegri JF. Fibroblast inhibition: A new and treatable cause of prosthetic graft failure. Am J Surg 1985; 149(5): 587-590.
150. Schneiderman J, Knoller S, Adar R, Savion N. Biochemical analysis of a human humoral fibroblast inhibitory factor associated with impaired vascular prosthetic graft incorporation. J Vasc Surg 1991; 14(1): 103-110.
151. Lowery RC Jr, Wicker HS, Sanders K, Peniston RL. Management of a recalcitrant periprosthetic fluid collection. J Vasc Surg 1987; 6(1): 77-80.
152. Moore WS, Hall AD. Late suture failure in the pathogenesis of anastomotic false aneurysms. Ann Surg 1970; 172(6): 1064-1068.
153. Cutler EC, Dunphy JE. The use of silk in infected wounds. N Engl J Med 1941; 224: 101-107.
154. Dobrin PB. Surgical manipulation and the tensile strength of polypropylene sutures. Arch Surg 1989; 124(6): 665-668.
155. Calhoun TR, Kitten CM. Polypropylene suture-is it safe? J Vasc Surg 1986; 4(1): 98-100.
156. Myhre OA. Breakage of prolene suture. Ann Thorac Surg 1983; 36(1): 121.
157. Szarnicki RJ. Polypropylene suture fracture. Ann Thorac Surg 1983; 35(3): 333.
158. Aldrete V. Polypropylene suture fracture. Ann Thorac Surg 1984; 37(3): 264.
159. Setzen G, Williams EF. Tissue response to suture materials implanted subcutaneously in a rabbit model. Plast Reconstr Surg 1997; 100(7): 1788-1795.
160. Gayle. RG, Wheeler JR, Gregory RT, Snyder SO JI. Evaluation of the expanded polytetrafluoroethylene (EPTFE) suture in peripheral vascular surgery using EPTFE prosthetic vascular grafts. J Cardiovasc Surg (Torino) 1988; 29(5): 556-559.
161. Moore WS, Kempczinski RF, Nelson JJ, Toole JF. Recurrent carotid stenosis: Results of the asymptomatic carotid atherosclerosis study. Stroke 1998; 29(10): 2018-2025.
162. O’Hara PJ, Hertzer NR, Mascha EJ, Krajewski LP, Clair DG, Ouriel K. A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. J Vasc Surg 2002; 35(2): 324-332.
163. Hayes PD, Allroggen H, Steel S, Thompson MM, London NJ, Bell PR, et al. Randomized trial of vein versus Dacron patching during carotid endarterectomy: Influence of patch type on postoperative embolization. J Vasc Surg 2001; 33(5): 994-1000.
164. AbuRahma AF, Khan JH, Robinson PA, Saiedy S, Short YS, Boland JP, et al. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: Perioperative (30-day) results. J Vasc Surg 1996; 24(6): 998-1007.
165. AbuRahma AF, Robinson PA, Saiedy S, Kahn JH, Boland JP. Prospective randomized trial of carotid endarterectomy with primary closure and patch angioplasty with saphenous vein, jugular vein, and polytetrafluoroethylene: Long-term follow-up. J Vasc Surg 1998; 27(2): 222-234.
166. AbuRahma AF, Hannay RS, Khan JH, Robinson PA, Hudson JK, Davis EA. Prospective randomized study of carotid endarterectomy with polytetrafluoroethylene versus collagenimpregnated Dacron (Hemashield) patching: perioperative (30-day) results. J Vasc Surg 2002; 35(1): 125-130.
167. AbuRahma AF, Robinson PA, Hannay RS, Hudson J, Cutlip L. Prospective controlled study of carotid endarterectomy with Hemashield patch: Is it thrombogenic? Vasc Surg 2001; 35(3): 167-174.
168. Archie JP. Carotid endarterectomy outcome with vein or Dacron graft patch angioplasty and internal carotid artery shortening. J Vasc Surg 1999; 29(4): 654-664.
169. Shi Q, Wu MH, Sauvage LR. Clinical and experimental demonstration of complete healing of porous Dacron patch grafts used for closure of the arteriotomy after carotid endarterectomy. Ann Vasc Surg 1999; 13(3): 313-317.
170. Grimsley BR, Wells JK, Pearl GJ, Garrett WV, Shutze WP, Talkington CM, et al. Bovine pericardial patch angioplasty in carotid endarterectomy. Am Surg 2001; 67(9): 890-895.
171. Biasi GM, Sternjakob S, Mingazzini PM, Ferrari SA. Nine-year experience of bovine pericardium patch angioplasty during carotid endarterectomy. J Vasc Surg 2002; 36(2): 271-277.
172. Rockman CB, Riles TS, Landis R, Lamparello PJ, Giangola G, Adelman MA, et al. Redo carotid surgery: An analysis of materials and configurations used in carotid reoperations and their influence on perioperative stroke and subsequent recurrent stenosis. J Vasc Surg 1999; 29(1): 72-81.
173. Lammer J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P, et al. Peripheral arterial obstruction: Prospective study of treatment with a transluminally placed self-expanding stentgraft. International Trial Study Group. Radiology 2000; 217(1): 95-1 04.
174. Marin ML, Veith FJ, Cynamon J, Sanchez LA, Bakal CW, Suggs WD. et al. Human transluminally placed endovascular stented grafts: preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg 1995; 21(4): 595-604.
175. van Sambeek MR, Hagenaars T, Gussenhoven EJ, Leertouwer TC, van der Lugt A, Hoedt MT, et al. Vascular response in the femoropopliteal segment after implantation of an ePTFE balloon-expandable endovascular graft: An intravascular ultrasound study. J Endovasc Ther 2000; 7(3): 204-212.
176. Sarkar R, Eilber FR, Gelabert HA, Quinones-Baldrich WJ. Prosthetic replacement of the inferior vena cava for malignancy. J Vasc Surg 1998; 28(1): 75-83.
177. Alimi YS, Gloviczki P, Vrtiska TJ, Pairolero PC, Canton LG, Bower TC, et al. Reconstruction of the superior vena cava: Benefits of postoperative surveillance and secondary endovascular interventions. J Vasc Surg 1998; 27(2): 287-301.
178. Rypins EB, Conroy RM, Sarfeh IJ. Advantages and disadvantages of polytetrafluoroethylene (PTFE) grafts for portacaval shunting. Vasc Surg 1988; 22(2): 88-92.
179. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204(4): 356-363.
180. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219(4): 353-361.
181. Sanders RJ, Rosales C, Pearce WH. Creation and closure of temporary arteriovenous fistulas for venous reconstruction or thrombectomy: Description of technique. J Vasc Surg 1987; 6(5): 504-505.
182. Kogel H, Vollmar JF, Cyba-Altunbay S, Mohr W, Frosch D, Amselgruber W. New observations on the healing process in prosthetic substitution of large veins by microporous grafts-animal experiments. Thorac Cardiovasc Surg 1989; 37(2): 119-124.
183. Heydorn WH, Geasling JW, Moores WY, Lollini LO, Gomez AC. Changes in the manufacture of expanded microporous polytetrafluoroethylene: Effects on patency and histological behavior when used to replace the superior vena cava. Ann Thorac Surg 1979; 27(2): 173-177.
184. Theuer CJ, Bergamini TM, Theuer HH, Burns CD, Proctor ML, Garrison RN. Vena cava replacement with a peritoneum-lined vascular graft. Asaio J 1996; 42(4): 266-270.
185. Glickman MH, Stokes GK, Ross JR, Schuman ED, Sternbergh WC III, Lindberg JS, et al. Multicenter evaluation of a polytetrafluoroethylene vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications. J Vasc Surg 2001; 34(3): 465-473.
186. King MW, Zhang Z, Ukpabi P, Murphy D, Guidoin R. Quantitative analysis of the surface morphology and textile structure of the polyurethane Vascugraft arterial prosthesis using image and statistical analyses. Biomaterials 1994; 15(8): 621-627.
187. Huang B, Marois Y, Roy R, Julien M, Guidoin R. Cellular reaction to the Vascugraft polyesterurethane vascular prosthesis: in vivo studies in rats. Biomaterials 1992; 13(4): 209-216.
188. Zhang Z, King MW, Guidoin R, Therrien M, Pezolet M, Adnot A, et al. Morphological, physical and chemical evaluation of the Vascugraft arterial prosthesis: Comparison of a novel polyurethane device with other microporous structures. Biomaterials 1994; 15(7): 483-501.
189. Bull PG, Denck H, Guidoin R, Gruber H. Preliminary clinical experience with polyurethane vascular prostheses in femoro-popliteal reconstruction. Eur J Vasc Surg 1992; 6(2): 217-224.
190. Zhang Z, Marois Y, Guidoin RG, Bull P, Marois M, How T, et al. Vascugraft polyurethane arterial prosthesis as femoro-popliteal and femoro-peroneal bypasses in humans: Pathological, structural and chemical analyses of four excised grafts. Biomaterials 1997; 18(2): 113124.
191. Stanley JC, Lindenauer SM, Graham LM, Zelenock GB, Wakefield TW, Cronenwett JL. Biologic and synthetic vascular grafts. In: Moore WS, ed. Vascular Surgery: A Comprehensive Review. Philadelphia: Saunders, 1990: 275-294.
192. Dardik H, Miller N, Dardik A, Ibrahim I, Sussman B, Berry SM, et al. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J Vasc Surg 1988; 7(2): 336-346.
193. Dardik H, Ibrahim IM, Sussman B, Kahn M, Sanchez M, Klausner S, et al. Biodegradation and aneurysm formation in umbilical vein grafts. Observations and a realistic strategy. Ann Surg 1984; 199(1): 61-68.
194. Guidoin R, Gagnon Y, Roy PE, Marois M, Johnston KW, Batt M. Pathologic features of surgically excised human umbilical vein grafts. J Vasc Surg 1986; 3(1): 146-154.
195. Batt M, Gagliardi JM, Avril G, Guzman R, Guidoin R, Hassen-Khodja R, et al. Human umbilical vein grafts as infrainguinal bypasses: Long-term clinical follow-up and pathological investigation of explanted grafts. Clin Invest Med 1990; 13(4): 155-164.
196. Cranely JJ, Karkow WS, Hafner CD, Flanagan LD. Aneurysmal dilatation in umbilical vein grafts. In: Yao JST, Bergan JJ, eds. Reoperative Arterial Surgery. New York: Grune and Straton, 1986: 343-358.
197. Dardik H, Wengerter K, Qin F, Pangilinan A, Silvestri F, Wolodiger F, et al. Comparative decades of experience with glutaraldehyde-tanned human umbilical cord vein graft for lower limb revascularization: An analysis of 1275 cases. J Vasc Surg 2002; 35(1): 64-71.
198. Matsuura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA, Kirby LB. Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 2000; 14(1): 50-55.
199. Johnson TR, Tomaszewski JE, Carpenter JP. Cellular repopulation of human vein allograft bypass grafts. J Vasc Surg 2000; 31(5): 994-1002.
200. Benedetto B, Lipkowitz G, Madden R, Kurbanov A, Hull D, Miller M, et al. Use of cryopreserved cadaveric vein allograft for hemodialysis access precludes kidney transplantation because of allosensitization. J Vasc Surg 2001; 34(1): 139-142.
201. Dalsing MC, Raju S, Wakefield TW, Taheri S. A multicenter, phase I evaluation of cryopreserved venous valve allografts for the treatment of chronic deep venous insufficiency. J Vasc Surg 1999; 30(5): 854-864.
202. Harris RW, Schneider PA, Andros G, Oblath RW, Salles-Cunha S, Dulawa L. Allograft vein bypass: Is it an acceptable alternative for infrapopliteal revascularization? J Vasc Surg 1993; 18(4): 553-560.
203. Buckley CJ, Abernathy S, Lee SD, Arko FR, Patterson DE, Manning LG. Suggested treatment protocol for improving patency of femoral-infrapopliteal cryopreserved saphenous vein allografts. J Vasc Surg 2000; 32(4): 731-738.
204. Harris L, O’Brien-Irr M, Ricotta JJ. Long-term assessment of cryopreserved vein bypass grafting success. J Vasc Surg 2001; 33(3): 528-532.
205. Vogt PR, Brunner-La Rocca HP, Carrel T, von Segesser LK, Ruef C, Debatin I, et al. Cryopreserved arterial allografts in the treatment of major vascular infection: A comparison with conventional surgical techniques. 1 Thorac Cardiovasc Surg 1998; 116(6): 965-972.
206. Leseche G, Castier Y, Petit MD. Bertrand P, Kitzis M, Mussot S, et al. Long-term results of cryopreserved arterial allograft reconstruction in infected prosthetic grafts and mycotic aneurysms of the abdominal aorta. J Vasc Surg 2001; 34(4): 616-622.
207. Rosenberg N. Dialdehyde starch tanned bovine heterografts. In: Sawyer P, Kaplitt Ml. eds. Vascular Grafts. New York: Appleton-Century-Crofts, 1978: 261-270.
208. Brems J, Castaneda M, Garvin PJ. A five-year experience with the bovine heterograft for vascular access. Arch Surg 1986; 121(8): 941-944.
209. Andersen RC, Ney AL, Madden MC, LaCombe MJ. Biologic conduits for vascular access: Saphenous veins, umbilical veins, bovine carotid arteries. In: Sommer BG, Henry ML, eds. Vascular Access for Hemodialysis. Chicago: Pluribus Press, 1989: 65-83.
210. Sabanayagam P, Schwartz AB, Soricelli RR, Lyons P, Chinitz J. A comparative study of 402 bovine heterografts and 225 reinforced expanded PTFE grafts as AVF in the ESRD patient. Trans Am Soc Artif Intern Organs 1980; 26: 88-92.
211. Hurt AV, Batello-Cruz M, Skipper BJ, Teaf SR, Sterling WA Jr, Bovine carotid artery heterografts versus polytetrafluoroethylene grafts. A prospective, randomized study. Am J Surg 1983; 146(6): 844-847.
212. Reese JC, Esterl R, Lindsey L, Aridge D, Solomon H, Fairchild RB, et al. A prospective randomized comparison of bovine heterografts versus Impra grafts for chronic hemodialysis. In: Henry ML, Ferguson RM, eds. Vascular Access for Hemodialysis-III. Chicago: Precept Press, 1993: 157-163.